Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Nutr.

Sec. Clinical Nutrition

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1680833

Perioperative Nutritional Interventions for Gastric Cancer Patients: A Meta-Analysis of Surgical Outcomes

Provisionally accepted
Junqi  LiJunqi LiChen  ChenChen ChenHongXiao  WangHongXiao Wang*
  • Huadong Hospital, Fudan University, Shanghai, China

The final, formatted version of the article will be published soon.

Objective: To assess the effectiveness of nutritional interventions such as multimodal nutrition interventions, dietary education and digital interventions, immunonutrition, and oral nutritional supplements (ONS) on clinical, immunological, and biochemical outcomes among gastric cancer patients. Background: Nutritional interventions become a key element in enhancing clinical, immunological, and biochemical outcomes in those who have gastric cancer and are receiving surgery, chemotherapy, or follow-up care after discharge. Methods: Eighteen randomized controlled trials (RCTs) were included, examining interventions like multimodal nutrition (EN, PN, probiotics, early oral feeding), dietary counseling, digital platforms, immunonutrition (ω-3, arginine, RNA-enriched formulas), and ONS. Primary outcomes were albumin (Nutritional marker used to assess malnutrition), CRP(C-reactive protein biomarker for systemic inflammation), IgA, interleukins, weight, quality of life, complications, and mortality. Data were pooled with a random-effects model with inverse variance methods to estimate standardized mean differences (SMD) with 95% confidence intervals (CI). Heterogeneity was measured using the I² statistic. Results: Separate studies indicated the following benefits with respective interventions: improvement in albumin, CRP, immunological markers, weight, quality of life, and fewer complications. Pooled analyses, however, revealed no statistically significant effects overall: multimodal nutrition (SMD -0.43, 95% CI -0.99 to 0.13), dietary counseling/education/digital interventions (SMD 0.27, 95% CI -0.34 to 0.88), immunonutrition (SMD -0.16, 95% CI -0.58 to 0.26), and ONS (SMD 0.07, 95% CI -0.27 to 0.41). Strong heterogeneity was identified for all interventions (I² range: 85–88%, p<0.01), indicating variability in study populations, intervention types, durations, and outcomes measured. Conclusions: Although single trials indicate nutritional interventions can enhance biochemical, immunological, and clinical responses in gastric cancer patients, pooled evidence fails to show overall consistent benefits. Substantial heterogeneity emphasizes the need for larger, uniform trials to establish proper nutritional interventions, formulations, and timing. These findings validate the potential usefulness of individually tailored nutritional support as an adjunct to conventional treatment.

Keywords: gastric cancer, nutritional interventions, Immunonutrition, oral nutritional supplements, dietary counseling, Multimodal nutrition, randomized controlled trials, Meta-analysis

Received: 06 Aug 2025; Accepted: 06 Oct 2025.

Copyright: © 2025 Li, Chen and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: HongXiao Wang, xhwangwang1122@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.